Authors:

Brill K. Norpoth T. Schnitker J. Albring M.

Institution

Medical Department, Pharmaceutical Division, Schering AG, Berlin; Germany.

Title:

Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users (1991-2109e).

Source:

Contraception. Vol 43(2) (pp01-110), 1991.

Abstract:

Efficacy, cycle control, tolerance, and adverse events were studied in a clinical Phase IV study using a new progestogen, gestodene, in an amount of 75 mug combined with 30 mug ethinylestradiol. The study was performed as a multicenter trial in 96,000 patients over a period of 6 cycles. Half of the patients taking the new preparation were fist-time OC users, the other half switched from another OC. With regard to contraceptive efficacy, the life-table analysis showed a value of 0.032% for method failure and 0.114% for patient failure. The correspondent Pearl-Index is 0.062 and 0.22. The new drug was found acceptable by more than 90% of the women involved in the trial. Dysmenorrhea present in the 'switchers' mostly disappeared on the new OC, while body weight and blood pressure remained virtually unchanged. Thus, it can be concluded that blood pressure and body weight behaviour is similar to that seen with other low-dose OCs. The new combined pill offers excellent cycle stability and has a very favourable effect on dysmenorrhea. The number of clinically diagnosed thrombotic events documented in this study was 0.65 per 1000 woman-years (TWY) and does not exceed the range of events seen in groups of women using non-hormonal methods of contraception (Oxford-FPA study 0.4/TWY and RCGP study 0.8/TWY).


women's health





Please click on the required question.

Women's Health

Thank you for choosing to visit us.


This is the personal website of David A Viniker MD FRCOG, Consultant Obstetrician and Gynaecologist at Whipps Cross University Hospital, London - Specialist Interests - Reproductive Medicine including Infertility, PCOS, PMS, Menopause and HRT.

I do hope that you find the answers to your women's health questions in the patient information and medical advice provided.

Women's Health Home Page





Your Own Web Presence

 

For £35

 

First Website Design

 

FirstWebSiteDesign.com

 

Have your own web ad on the internet and optimized for good positioning.

 

Your Own Dedicated Web Page Designed Specifically For You

 

More Effective

Than Your Own

Single Page Website

 

For £35

 

First Website Design

 

FirstWebSiteDesign.com